Scientists track weekly pTau-217 fluctuations in Alzheimer's study
NCT ID NCT06742944
First seen Jan 06, 2026 · Last updated May 24, 2026 · Updated 17 times
Summary
This study involved 100 adults aged 50-80 with normal cognition or mild impairment. Researchers took 10 weekly blood samples from each person to see how a key Alzheimer's biomarker, pTau-217, changes over time. The goal was to understand normal fluctuations and identify unexpected spikes that could affect clinical decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Banner Alzheimer's Institute
Phoenix, Arizona, 85006, United States
-
Banner Alzheimer's Institute Tucson
Tucson, Arizona, 85718, United States
Conditions
Explore the condition pages connected to this study.